Literature DB >> 6628526

Renal clearance of digoxin in man after sodium loading or furosemide treatment.

M A Naafs, C van der Hoek, W Schopman, S van Duin, G Koorevaar, J Silberbusch.   

Abstract

To evaluate the influence of different types of natriuresis on the renal clearance of digoxin (Cldig) and the Cldig/Clcr ratio, studies were performed in which sodium-depleted patients were placed on a moderately high sodium diet for 6 days. In another group natriuresis was evoked by furosemide. In the first study, in 10 patients, there was a 10-fold increase in Na excretion and a small rise in diuresis (V) and Clcr, which was accompanied by an increase in Cldig from 57.5 +/- 32, and 60.7 +/- 27.3 (duplicate measurements) to 103.9 +/- 55.4 (p less than 0.01) and 103.8 +/- 46.5 ml min-1 (p less than 0.01). Cldig/Clcr rose from 0.60 +/- 0.24 and 0.61 +/- 0.16 to 0.91 +/- 0.31 and 0.91 +/- 0.21, respectively (both p less than 0.005). Serum digoxin concentration declined from 1.24 +/- 0.35 and 1.19 +/- 0.40 to 1.02 +/- 0.35 and 0.97 +/- 0.32 micrograms/l (both p less than 0.01) during the high sodium diet. In the furosemide-induced natriuresis (6 patients), changes in Na excretion and V were a multiple of those caused by Na loading, but the Cldig/Clcr ratio was not increased. The results are in accordance with the concept of digoxin backdiffusion in the proximal tubules, which is dependent on proximal Na reabsorption. In the more distal segments of the nephron, where the action of furosemide occurs, there does not appear to be any transtubular movement of digoxin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628526     DOI: 10.1007/bf01037951

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Letter: Furosemide and urinary digoxin clearance.

Authors:  P Sempler; W J Tilstone; D H Lawson
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

2.  Determinants of the renal clearance of digoxin.

Authors:  H Halkin; L B Sheiner; C C Peck; K L Melmon
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

3.  INFLUENCE OF EXPANSION OF EXTRACELLULAR VOLUME ON TUBULAR REABSORPTION OF SODIUM INDEPENDENT OF CHANGES IN GLOMERULAR FILTRATION RATE AND ALDOSTERONE ACTIVITY.

Authors:  F C RECTOR; G VANGIESEN; F KIIL; D W SELDIN
Journal:  J Clin Invest       Date:  1964-03       Impact factor: 14.808

4.  THE EFFECTS OF SALINE INFUSION ON SODIUM REABSORPTION BY THE PROXIMAL TUBULE OF THE DOG.

Authors:  J H DIRKS; W J CIRKSENA; R W BERLINER
Journal:  J Clin Invest       Date:  1965-07       Impact factor: 14.808

5.  Effect of intravenous furosemide on the renal excretion of digoxin.

Authors:  R G McAllister; S M Howell; M S Gomer; J B Selby
Journal:  J Clin Pharmacol       Date:  1976 Feb-Mar       Impact factor: 3.126

6.  Renal tubular secretion of digoxin.

Authors:  E Steiness
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

7.  Effect of volume expansion and furosemide diuresis on the renal clearance of digoxin.

Authors:  T P Gibson; A P Quintanilla
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

8.  Effects of quinidine on serum digoxin concentration: a prospective study.

Authors:  D R Mungall; R P Robichaux; W Perry; J W Scott; A Robinson; T Burelle; D Hurst
Journal:  Ann Intern Med       Date:  1980-11       Impact factor: 25.391

9.  Effect of furosemide on the renal excretion of digoxin.

Authors:  D D Brown; J C Dormois; G N Abraham; K Lewis; K Dixon
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

10.  Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.

Authors:  J J Cogan; M H Humphreys; C J Carlson; N L Benowitz; E Rapaport
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

View more
  4 in total

Review 1.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

2.  Interaction study of fenoldopam--digoxin in congestive heart failure.

Authors:  E Strocchi; F Tartagni; P L Malini; G Valtancoli; E Ambrosioni; F Pasinelli; E Riva; L M Fuccella
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Decreased renal clearance of digoxin in chronic congestive heart failure.

Authors:  M A Naafs; C van der Hoek; S van Duin; G Koorevaar; W Schopman; J Silberbusch
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin.

Authors:  P Stopfer; T Giessmann; K Hohl; A Sharma; N Ishiguro; M E Taub; H Zimdahl-Gelling; D Gansser; M Wein; T Ebner; F Müller
Journal:  Clin Pharmacol Ther       Date:  2016-07-29       Impact factor: 6.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.